← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity

ATEC logoAlphatec Holdings, Inc.(ATEC)Earnings, Financials & Key Ratios

ATEC•NASDAQ
$6.99
$1.06B mkt cap·Price updated May 6, 2026
SectorHealthcareIndustryMedical DevicesSub-IndustryOrthopedics, spine, and sports medicine
AboutAlphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; Sigma transforaminal lumbar interbody fusion pedicle-based access system that provides direct visualization of anatomical landmarks; Sigma PTP Access and Patient Positioning System; squadron lateral retractor designed to maximize patient outcomes; Invictus Spinal Fixation System, a thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep System that provides minimally invasive pedicle screw placement. It also provides Invictus Modular Fixation Systems designed to increase adaptability with the power of screw modularity; OsseoScrew system to restore the integrity of the spinal column; Arsenal spinal fixation system, a comprehensive thoracolumbar fixation platform to fix a range of degenerative to deformity pathologies and surgical procedures; Aspida Anterior Lumbar Plating System, a fixation system for anterior lumbar interbody fusion; AMP Anti-Migration Plate; OCT Spinal Fixation System; trestle luxe anterior cervical plate system; and Insignia Anterior Cervical Plate System. In addition, the company offers IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Interbody Implants; and biologics consisting of Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier, as well as EOS imaging products. It sells its products through a network of independent distributors and direct sales representatives in the United States. The company was founded in 1990 and is headquartered in Carlsbad, California.Show more
  • Revenue$764M+25.0%
  • EBITDA$435K+100.8%
  • Net Income-$143M+11.6%
  • EPS (Diluted)-0.96+15.0%
  • Gross Margin69.6%+0.3%
  • EBITDA Margin0.06%+100.7%
  • Operating Margin-10.75%+51.7%
  • Net Margin-18.76%+29.2%
  • ROE-630.66%-116.2%
  • ROIC-12.63%+44.2%
  • Debt/Equity17.21-73.4%
  • Interest Coverage-5.78-4.9%
Technical→

ATEC Key Insights

Alphatec Holdings, Inc. (ATEC) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Strong 5Y sales CAGR of 39.5%

✗Weaknesses

  • ✗High debt to equity ratio of 17.2x
  • ✗Profits declining 12.7% over 5 years
  • ✗Weak momentum: RS Rating 10 (bottom 10%)
  • ✗Trading more than 30% below 52-week high
  • ✗Expensive at 29.1x book value

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

ATEC Price & Volume

Alphatec Holdings, Inc. (ATEC) stock price & volume — 10-year historical chart

Loading chart...

ATEC Growth Metrics

Alphatec Holdings, Inc. (ATEC) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years15.22%
5 Years39.46%
3 Years29.62%
TTM-7.36%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM24.27%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM27.83%

Return on Capital

10 Years-30.18%
5 Years-28.22%
3 Years-22.95%
Last Year-13.75%

ATEC Recent Earnings

Alphatec Holdings, Inc. (ATEC) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 3/12 qtrs (25%)●Beat Revenue 6/12 qtrs (50%)
Q2 2026Latest
May 5, 2026
EPS
$0.22
Est $0.01
-2100.0%
Revenue
$192M
Est $198M
-2.7%
Q1 2026
Feb 24, 2026
EPS
$0.06
Est $0.04
+50.0%
Revenue
$213M
Est $212M
+0.7%
Q4 2025
Oct 30, 2025
EPS
$0.03
Est $0.03
+200.0%
Revenue
$197M
Est $209M
-6.1%
Q3 2025
Jul 31, 2025
EPS
$0.02
Est $0.06
+133.3%
Revenue
$186M
Est $183M
+1.6%
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 5, 2026
$0.22vs $0.01-2100.0%
$192Mvs $198M-2.7%
Q1 2026Feb 24, 2026
$0.06vs $0.04+50.0%
$213Mvs $212M+0.7%
Q4 2025Oct 30, 2025
$0.03vs $0.03+200.0%
$197Mvs $209M-6.1%
Q3 2025Jul 31, 2025
$0.02vs $0.06+133.3%
$186Mvs $183M+1.6%
Based on last 12 quarters of dataView full earnings history →

ATEC Peer Comparison

Alphatec Holdings, Inc. (ATEC) competitors in Orthopedics, spine, and sports medicine — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
NUVL logoNUVLNuvalent, Inc.Direct Competitor6.92B104.26-26.53-45.12%
XTNT logoXTNTXtant Medical Holdings, Inc.Direct Competitor80.8M0.58-4.8128.44%1.32%3.77%0.82
GMED logoGMEDGlobus Medical, Inc.Direct Competitor12.07B89.2222.7616.65%18.3%12.4%0.03
SYK logoSYKStryker CorporationProduct Competitor111.96B292.3334.8011.16%12.92%15.04%0.66
ZBH logoZBHZimmer Biomet Holdings, Inc.Product Competitor16.22B82.8323.337.2%9.05%5.77%0.59
MDT logoMDTMedtronic plcProduct Competitor99.48B77.6021.503.62%13%9.45%0.59
NUS logoNUSNu Skin Enterprises, Inc.Product Competitor353.79M7.342.31-14.26%7.02%13.7%0.35
NVCR logoNVCRNovoCure LimitedProduct Competitor1.88B16.50-13.528.28%-25.66%-50.82%0.85

Compare ATEC vs Peers

Alphatec Holdings, Inc. (ATEC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs NUVL

Most directly comparable listed peer for ATEC.

Scale Benchmark

vs ISRG

Larger-name benchmark to compare ATEC against a more recognizable public peer.

Peer Set

Compare Top 5

vs NUVL, XTNT, GMED, SYK

ATEC Income Statement

Alphatec Holdings, Inc. (ATEC) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue101.74M91.69M113.43M144.86M243.21M350.87M482.26M611.56M764.15M594.98M
Revenue Growth %-15.39%-9.87%23.7%27.71%67.89%44.26%37.45%26.81%24.95%-7.36%
Cost of Goods Sold39.41M28.46M35.83M42.36M85.45M117.81M172.06M187.3M232.27M198.18M
COGS % of Revenue38.73%31.03%31.59%29.24%35.13%33.58%35.68%30.63%30.4%-
Gross Profit
62.33M▲ 0%
63.24M▲ 1.5%
77.59M▲ 22.7%
102.5M▲ 32.1%
157.76M▲ 53.9%
233.06M▲ 47.7%
310.2M▲ 33.1%
424.26M▲ 36.8%
531.89M▲ 25.4%
533.27M▲ 0%
Gross Margin %61.27%68.97%68.41%70.76%64.87%66.42%64.32%69.37%69.6%89.63%
Gross Profit Growth %-18.13%1.45%22.7%32.1%53.91%47.73%33.1%36.77%25.37%-
Operating Expenses69.99M83.23M124.87M161.36M285.82M380.03M483.6M560.43M614.02M590.23M
OpEx % of Revenue68.79%90.77%110.09%111.39%117.52%108.31%100.28%91.64%80.35%-
Selling, General & Admin64.38M72.51M101.71M129.16M229.27M300.01M374.08M450.2M498.53M493.34M
SG&A % of Revenue63.28%79.08%89.67%89.16%94.27%85.51%77.57%73.61%65.24%-
Research & Development4.92M9.98M13.85M18.75M32.02M44.03M70.11M80.72M76.27M77.25M
R&D % of Revenue4.84%10.89%12.21%12.94%13.16%12.55%14.54%13.2%9.98%-
Other Operating Expenses0738K9.31M13.46M24.53M35.99M39.4M29.51M39.22M3M
Operating Income
-9M▲ 0%
-22.44M▼ 149.3%
-47.28M▼ 110.7%
-58.86M▼ 24.5%
-128.06M▼ 117.6%
-146.97M▼ 14.8%
-173.4M▼ 18.0%
-136.17M▲ 21.5%
-82.13M▲ 39.7%
-56.96M▲ 0%
Operating Margin %-8.85%-24.47%-41.68%-40.63%-52.65%-41.89%-35.95%-22.27%-10.75%-9.57%
Operating Income Growth %41.45%-149.25%-110.68%-24.51%-117.55%-14.77%-17.98%21.47%39.69%-
EBITDA-1.52M-15.65M-38.77M-47.23M-97.88M-103.05M-113.71M-52.85M435K4.42M
EBITDA Margin %-1.5%-17.07%-34.18%-32.6%-40.25%-29.37%-23.58%-8.64%0.06%0.74%
EBITDA Growth %49.49%-928.32%-147.7%-21.83%-107.24%-5.28%-10.35%53.52%100.82%106.07%
D&A (Non-Cash Add-back)7.48M6.79M8.51M11.63M30.17M43.93M59.68M83.32M82.56M61.38M
EBIT3.04M-23.03M-47.28M-66.47M-137.05M-146.5M-170.27M-137.19M-122.26M-61.06M
Net Interest Income-7.62M-7.14M-9.87M-12.37M-7.11M-5.5M-16.64M-24.88M-21.14M-30.37M
Interest Income009.87M0000000
Interest Expense7.62M7.14M012.37M7.11M5.5M16.64M24.88M21.14M25.42M
Other Income/Expense4.43M-7.73M-9.87M-19.99M-16.11M-5.03M-13.52M-25.9M-61.27M-68.33M
Pretax Income
-4.57M▲ 0%
-30.17M▼ 559.6%
-57.14M▼ 89.4%
-78.85M▼ 38.0%
-144.16M▼ 82.8%
-152.01M▼ 5.4%
-186.91M▼ 23.0%
-162.07M▲ 13.3%
-143.4M▲ 11.5%
-125.29M▲ 0%
Pretax Margin %-4.5%-32.9%-50.38%-54.43%-59.27%-43.32%-38.76%-26.5%-18.77%-21.06%
Income Tax-34K-1.36M-239K145K-1.13M-716K-277K50K-45K69K
Effective Tax Rate %0.74%4.51%0.42%-0.18%0.78%0.47%0.15%-0.03%0.03%-0.06%
Net Income
-2.29M▲ 0%
-28.98M▼ 1163.1%
-57M▼ 96.7%
-78.99M▼ 38.6%
-143.03M▼ 81.1%
-151.29M▼ 5.8%
-186.64M▼ 23.4%
-162.12M▲ 13.1%
-143.36M▲ 11.6%
-125.36M▲ 0%
Net Margin %-2.25%-31.6%-50.25%-54.53%-58.81%-43.12%-38.7%-26.51%-18.76%-21.07%
Net Income Growth %92.43%-1163.08%-96.73%-38.58%-81.07%-5.78%-23.36%13.14%11.57%24.27%
Net Income (Continuing)-4.54M-28.81M-56.9M-78.99M-143.03M-151.29M-186.64M-162.12M-143.36M-125.36M
Discontinued Operations2.25M0-100K0000000
Minority Interest0000000000
EPS (Diluted)
-0.17▲ 0%
-0.82▼ 382.4%
-1.09▼ 32.9%
-1.18▼ 8.3%
-1.50▼ 27.1%
-1.47▲ 2.0%
-1.54▼ 4.8%
-1.13▲ 26.6%
-0.96▲ 15.0%
-0.81▲ 0%
EPS Growth %95.18%-382.35%-32.93%-8.26%-27.12%2%-4.76%26.62%15.04%27.83%
EPS (Basic)-0.18-0.82-1.09-1.18-1.50-1.47-1.54-1.13-0.96-
Diluted Shares Outstanding13.28M35.31M52.23M67.02M96.2M103.37M121.24M142.95M150.06M154.05M
Basic Shares Outstanding12.79M35.31M52.23M67.02M96.2M103.37M121.24M142.95M150.06M154.05M
Dividend Payout Ratio----------

ATEC Balance Sheet

Alphatec Holdings, Inc. (ATEC) balance sheet — assets, liabilities & shareholders' equity

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets66.48M75.54M108.32M184.16M331.16M255.63M451.09M417.4M450.88M456.17M
Cash & Short-Term Investments22.47M29.05M47.11M107.77M187.25M84.7M220.97M138.84M160.81M139.91M
Cash Only22.47M29.05M47.11M107.77M187.25M84.7M220.97M138.84M160.81M139.91M
Short-Term Investments0000000000
Accounts Receivable14.82M15.45M16.15M24.6M41.89M60.06M72.61M82.99M97.3M106.38M
Days Sales Outstanding53.1861.4851.9761.9962.8762.4854.9649.5346.4861.41
Inventory27.29M28.77M34.85M46M91.7M101.52M136.84M175.26M169.44M186.03M
Days Inventory Outstanding252.79368.95355.03396.37391.71314.54290.29341.54266.28318.67
Other Current Assets131K242K10.2M5.79M09.36M20.67M20.31M23.32M23.85M
Total Non-Current Assets18.18M53.94M66.63M81.06M240.9M265.33M354.12M358.31M340.33M343.31M
Property, Plant & Equipment12.67M13.23M21.58M37.85M112.68M130.31M176.25M191.09M166.55M168.65M
Fixed Asset Turnover8.03x6.93x5.26x3.83x2.16x2.69x2.74x3.20x4.59x3.50x
Goodwill013.9M13.9M13.9M39.69M47.37M73M70.98M75.21M74.47M
Intangible Assets5.25M26.41M25.61M24.72M85.27M82.78M102.45M93.52M93.45M90.02M
Long-Term Investments5M5M5M4M000000
Other Non-Current Assets264K401K546K599K3.25M4.87M2.42M2.72M5.12M23.19M
Total Assets
84.66M▲ 0%
129.48M▲ 52.9%
174.95M▲ 35.1%
265.22M▲ 51.6%
572.05M▲ 115.7%
520.97M▼ 8.9%
805.21M▲ 54.6%
775.71M▼ 3.7%
791.21M▲ 2.0%
799.48M▲ 0%
Asset Turnover1.20x0.71x0.65x0.55x0.43x0.67x0.60x0.79x0.97x0.75x
Asset Growth %-10.12%52.94%35.12%51.6%115.69%-8.93%54.56%-3.66%2%12.15%
Total Current Liabilities29.74M30.61M36.39M58.31M101.09M138.87M157.57M153.03M219.18M240.24M
Accounts Payable3.88M4.4M7.77M17.6M25.74M34.74M48.98M52.98M40.89M46.04M
Days Payables Outstanding35.9256.4279.17151.64109.94107.64103.92103.2564.2678.76
Short-Term Debt3.31M3.28M1.8M5.08M342K14.95M1.81M1.66M70.82M72.17M
Deferred Revenue (Current)19.11M-3K0015.26M11.96M13.91M10.47M10.44M32.01M
Other Current Liabilities15.11M19.71M18.78M23.38M4.29M5.64M56.52M6.82M63.67M122.03M
Current Ratio2.24x2.47x2.98x3.16x3.28x1.84x2.86x2.73x2.06x2.06x
Quick Ratio1.32x1.53x2.02x2.37x2.37x1.11x1.99x1.58x1.28x1.28x
Cash Conversion Cycle270.05374.01327.83306.72344.64269.38241.33287.82248.49301.33
Total Non-Current Liabilities81.58M81.29M66.32M49.43M391.54M416.76M545.91M613.25M536M300.73M
Long-Term Debt37.77M42.3M53.38M38M326.49M349.51M511.04M574.52M525.27M530.89M
Capital Lease Obligations092K989K78K24.38M26.56M23.68M27.3M23.86M75.09M
Deferred Tax Liabilities0000000000
Other Non-Current Liabilities43.81M38.9M11.95M11.35M37.77M37.65M8.64M8.29M-15.3M61.24M
Total Liabilities111.32M111.9M102.71M107.74M492.63M555.63M703.49M766.28M755.18M540.98M
Total Debt41.07M3.28M56.18M43.16M355.43M395.86M541.68M609.94M619.95M72.17M
Net Debt18.61M-25.78M9.06M-64.61M168.18M311.17M320.71M471.1M459.14M-67.75M
Debt / Equity-0.19x0.78x0.27x4.48x-5.33x64.65x17.21x17.21x
Debt / EBITDA--------1425.17x16.31x
Net Debt / EBITDA--------1055.50x1055.50x
Interest Coverage0.40x-3.23x--5.37x-19.28x-26.61x-10.23x-5.51x-5.78x-2.40x
Total Equity
-26.66M▲ 0%
17.57M▲ 165.9%
72.23M▲ 311.0%
157.48M▲ 118.0%
79.42M▼ 49.6%
-34.67M▼ 143.6%
101.72M▲ 393.4%
9.43M▼ 90.7%
36.03M▲ 281.9%
258.5M▲ 0%
Equity Growth %36.37%165.92%311.03%118.02%-49.57%-143.65%393.42%-90.73%281.91%764.69%
Book Value per Share-2.010.501.382.350.83-0.340.840.070.241.68
Total Shareholders' Equity-26.66M17.57M72.23M157.48M79.42M-34.67M101.72M9.43M36.03M258.5M
Common Stock2K4K6K8K10K11K14K14K15K16K
Retained Earnings-459.46M-501.92M-558.92M-638M-782.33M-932.32M-1.12B-1.28B-1.42B-1.46B
Treasury Stock-97K-97K-97K-97K-25.1M-25.1M-25.1M-25.1M-25.1M0
Accumulated OCI1.09M1.06M1.09M1.2M-5.99M-10.79M-8.32M-13.68M-4.43M-6.45M
Minority Interest0000000000

ATEC Cash Flow Statement

Alphatec Holdings, Inc. (ATEC) cash flow — operating, investing & free cash flow history

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations-8.73M-25.61M-33.12M-46.41M-73.32M-75.13M-78.48M-44.65M45.23M45.23M
Operating CF Margin %-8.58%-27.93%-29.2%-32.04%-30.15%-21.41%-16.27%-7.3%5.92%-
Operating CF Growth %12.35%-193.37%-29.34%-40.13%-57.97%-2.48%-4.46%43.11%201.3%821.44%
Net Income-2.29M-28.98M-57M-78.99M-143.03M-151.29M-186.64M-162.12M-143.36M-125.36M
Depreciation & Amortization7.48M6.79M8.51M11.63M30.17M43.93M59.68M83.32M105.08M88.73M
Stock-Based Compensation3.9M5.3M10.96M17.66M36.45M40.56M81.24M73.28M73.72M75.06M
Deferred Taxes-36K-1.41M-438K9K000000
Other Non-Cash Items-7.48M2.39M13.23M19.23M28.15M15.61M21.41M28.15M29.92M41.61M
Working Capital Changes-10.3M-9.71M-8.38M-15.95M-25.05M-23.94M-54.18M-67.27M-20.13M-28.48M
Change in Receivables4.15M-396K-1.3M-7.48M-10.14M-18.83M-12.79M-14.59M-21.88M-21.84M
Change in Inventory258K-6.02M-14.71M-18.19M-27.75M-20.7M-45.56M-54.66M13.54M15.91M
Change in Payables-2.59M16K6M7.13M757K9.8M6.99M9.67M-11.16M963K
Cash from Investing-6.5M-21.67M-13.03M-23.86M-157.76M-58.28M-141.97M-93.14M-53.41M-61.69M
Capital Expenditures-7.6M-6.91M-13.03M-23.13M-68.54M-49.45M-80.51M-93.14M-42.45M-44.61M
CapEx % of Revenue7.47%7.54%11.49%15.97%28.18%14.09%16.69%15.23%5.56%-
Acquisitions1.1M-15.1M00-83.23M0-55M000
Investments----------
Other Investing1.1M348K0-728K0-8.83M-6.47M0-10.96M-17.08M
Cash from Financing17.82M53.88M64.18M130.83M311.97M31.23M356.92M56.21M30.02M-2.52M
Debt Issued (Net)-6.57M1.98M8.36M19.85M271.25M35M149.66M58.8M74.81M-1.1M
Equity Issued (Net)24.39M51.9M55.83M111.04M100.86M0212.12M-560K0-54K
Dividends Paid0000000000
Share Repurchases0000-30.96M00000
Other Financing24.39M00-58K-60.15M-3.77M-4.86M-2.03M-44.8M-1.36M
Net Change in Cash
2.84M▲ 0%
6.59M▲ 131.9%
18.06M▲ 174.1%
60.65M▲ 235.9%
79.48M▲ 31.0%
-102.55M▼ 229.0%
136.27M▲ 232.9%
-82.13M▼ 160.3%
21.97M▲ 126.7%
-13.33M▲ 0%
Free Cash Flow
-16.32M▲ 0%
-32.52M▼ 99.2%
-46.15M▼ 41.9%
-70.3M▼ 52.3%
-141.86M▼ 101.8%
-133.41M▲ 6.0%
-165.46M▼ 24.0%
-137.79M▲ 16.7%
2.78M▲ 102.0%
6.95M▲ 0%
FCF Margin %-16.05%-35.47%-40.69%-48.53%-58.33%-38.02%-34.31%-22.53%0.36%1.17%
FCF Growth %14.56%-99.22%-41.91%-52.32%-101.8%5.95%-24.02%16.72%102.01%108.61%
FCF per Share-1.23-0.92-0.88-1.05-1.47-1.29-1.36-0.960.020.02
FCF Conversion (FCF/Net Income)3.81x0.88x0.58x0.59x0.51x0.50x0.42x0.28x-0.32x-0.06x
Interest Paid4.7M5.14M5.97M6.33M5.03M3.86M17.27M20.32M00
Taxes Paid107K134K161K190K223K272K333K275K00

ATEC Key Ratios

Alphatec Holdings, Inc. (ATEC) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Return on Equity (ROE)--164.87%-126.94%-68.78%-120.75%-676.09%-556.7%-291.71%-630.66%-141.88%
Return on Invested Capital (ROIC)---97.02%-50.69%-56.42%-42.07%-37.21%-22.62%-12.63%-12.63%
Gross Margin61.27%68.97%68.41%70.76%64.87%66.42%64.32%69.37%69.6%89.63%
Net Margin-2.25%-31.6%-50.25%-54.53%-58.81%-43.12%-38.7%-26.51%-18.76%-21.07%
Debt / Equity-0.19x0.78x0.27x4.48x-5.33x64.65x17.21x17.21x
Interest Coverage0.40x-3.23x--5.37x-19.28x-26.61x-10.23x-5.51x-5.78x-2.40x
FCF Conversion3.81x0.88x0.58x0.59x0.51x0.50x0.42x0.28x-0.32x-0.06x
Revenue Growth-15.39%-9.87%23.7%27.71%67.89%44.26%37.45%26.81%24.95%-7.36%

ATEC SEC Filings & Documents

Alphatec Holdings, Inc. (ATEC) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 5, 2026·SEC

Material company update

Mar 3, 2026·SEC

Material company update

Feb 24, 2026·SEC

10-K Annual Reports

3
FY 2026

Feb 24, 2026·SEC

FY 2025

Feb 26, 2025·SEC

FY 2024

Feb 27, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 5, 2026·SEC

FY 2025

Oct 30, 2025·SEC

FY 2025

Jul 31, 2025·SEC

ATEC Frequently Asked Questions

Alphatec Holdings, Inc. (ATEC) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Alphatec Holdings, Inc. (ATEC) reported $595.0M in revenue for fiscal year 2025. This represents a 3239% increase from $17.8M in 2004.

Alphatec Holdings, Inc. (ATEC) grew revenue by 25.0% over the past year. This is strong growth.

Alphatec Holdings, Inc. (ATEC) reported a net loss of $125.4M for fiscal year 2025.

Dividend & Returns

Alphatec Holdings, Inc. (ATEC) has a return on equity (ROE) of -630.7%. Negative ROE indicates the company is unprofitable.

Alphatec Holdings, Inc. (ATEC) generated $6.9M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More ATEC

Alphatec Holdings, Inc. (ATEC) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.